RANDOMIZED PROTEOMIC STRATIFIED PHASE III STUDY OF SECOND LINE ERLOTINIB (E) VERSUS CHEMOTHERAPY (CT) IN PATIENTS WITH INOPERABLE NON-SMALL CELL LUNG CANCER (PROSE): VERISTRAT ANALYSIS OF LONGITUDINAL SAMPLES
JOURNAL OF THORACIC ONCOLOGY(2013)
关键词
treatment monitoring,EGFR-TKIs,mass spectrometry
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要